Code | 7765E | ||||||||||
MA number | EU/1/24/1864/001 | ||||||||||
Product Form: | plc ifc 1x150 mg (liek.inj.skl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Prestige Biopharma Belgium BVBA, Belgium | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 48 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(4) similar biological application |
MA issued: | 19.09.2024 |
Validity: | 19.09.2029 |
SmPC + PL: | European Medicines Agency's database |
Safety feature | Yes |
Data update: | 16.10.2024 |